HESI CASE STUDY ON BENIGN PROSTATIC HYPERPLASIA

Please review our privacy policy. Deterioration of symptoms Deterioration of flow rate Risk of acute urinary retention AUR Risk of surgery What is the most appropriate medical therapy? This patient desires therapy because his symptoms are interfering with his daily activities and affecting his quality of life. Strong evidence exists that the patient will do well on long-term combination therapy. The patient states that he is not bothered significantly by his symptoms and does not desire active therapy. Case 1 A year-old man presents with a 4-year progressive history of: Combination therapy will produce the most clinically significant response, in terms of long-term amelioration of symptoms and reduction in risk of BPH progression ie, symptom deterioration, AUR, and need for surgery.

The patient declines therapy. Although bothered by his symptoms, this patient has a low risk of BPH progression. The patient is happy with this therapy but questions whether he needs to continue both medications for the rest of his life. When deciding between watchful waiting and active treatment, this patient should be aware of his increased risk of BPH progression and unfavorable outcomes. This patient is at significant risk for BPH progression: Case 4 A year-old man presents with a 4-year progressive history of:

This patient is at significant risk for benign prostatic hyperplasia BPH progression:. Case 1 Bnign year-old man presents with a 4-year progressive history of: Although bothered by his symptoms, this patient has a low risk of BPH progression. Journal List Rev Urol v. Within several weeks he experiences significant symptom amelioration and quality-of-life improvement.

  RUGMAKER CONTEXT ESSAY

Strong evidence exists that the patient will do well on long-term combination therapy. Case 4 A year-old man presents with a 4-year progressive history of: Case 2 A year-old man porstatic a 2-year history of increasing voiding symptoms: Combination therapy will produce the most clinically significant response, in terms of long-term amelioration of symptoms and reduction in risk of BPH progression ie, symptom deterioration, AUR, and need for surgery.

The patient is happy with this therapy but questions whether he needs to continue both medications for the rest of his life. He reports significant symptom improvement and quality-of-life improvement.

A year-old man with a 5-year history of increasing voiding symptoms:. The patient declines therapy.

This patient is at significant risk for BPH progression: This patient desires therapy because his symptoms are interfering with his daily activities and affecting his quality of life.

The patient states that he is not bothered significantly by his symptoms and does not desire active therapy.

  HOMEWORK LLC DEIRA

hesi case study on benign prostatic hyperplasia

What is his risk of progression? Support Center Support Center.

Benign Prostatic Hyperplasia: Case Scenarios

Please review our privacy policy. Deterioration of symptoms Deterioration of prodtatic rate Risk of acute urinary retention AUR Risk of surgery What is the most appropriate medical therapy? This patient has a reasonable chance for long-term symptom amelioration, but would experience greater improvement with combination therapy. National Center for Biotechnology InformationU. What is the most appropriate medical therapy?

Close follow-up is required to detect significant progression.

Benign Prostatic Hyperplasia: Case Scenarios

Author information Copyright and License information Disclaimer. This patient is at significant risk for benign prostatic hyperplasia BPH progression: Case 3 A year-old man with a 5-year history of increasing voiding symptoms: When deciding between watchful waiting and active treatment, this patient should be aware of his increased risk of BPH progression and unfavorable outcomes.

hesi case study on benign prostatic hyperplasia

A year-old man has a 2-year history of increasing voiding symptoms:. Implications for medical therapy: